Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-25 @ 4:12 PM
NCT ID:
NCT02196857
Group ID:
EG000
Title:
Azacytidine + Sorafenib
Description:
Azacitidine 75 mg/m2 administered subcutaneously (SQ) or intravenously (IV) daily for 7 days per 28 day cycle. Sorafenib administered orally at a dose of 400 mg twice daily every day continuously.
Azacytidine: 75 mg/m2 administered subcutaneously (SQ) or intravenously (IV) on Days 1 - 7 for a 28 day cycle.
Sorafenib: 400 mg by mouth twice daily about 12 hours apart, every day for a 28 day cycle.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
16
Other Number Affected:
6
Other Number At Risk:
16
Study:
NCT02196857
Results Section:
NCT02196857
Adverse Events Module:
NCT02196857